Compare RGNX & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGNX | SRTA |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | 601 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.1M | 352.3M |
| IPO Year | 2015 | N/A |
| Metric | RGNX | SRTA |
|---|---|---|
| Price | $8.38 | $4.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $28.75 | $7.81 |
| AVG Volume (30 Days) | ★ 794.1K | 742.8K |
| Earning Date | 03-05-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $50.05 | $39.67 |
| Revenue Next Year | $23.31 | $8.84 |
| P/E Ratio | ★ N/A | $9.88 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.04 | $3.85 |
| 52 Week High | $16.19 | $6.02 |
| Indicator | RGNX | SRTA |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 42.67 |
| Support Level | $7.81 | $3.93 |
| Resistance Level | $9.28 | $5.46 |
| Average True Range (ATR) | 0.47 | 0.21 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 46.82 | 23.53 |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.